CJC-1295 NO DAC (Mod GRF 1-29) (5mg) Dosage Protocol
CJC-1295 without DAC (also known as Mod GRF 1-29) is a modified growth hormone releasing hormone analog with a shorter half-life than the DAC version. It provides pulsatile GH release similar to natural physiology.
Add 2.5 mL bacteriostatic water → 2 mg/mL (2000 mcg/mL)
100-300 mcg per injection, 2-3x daily
At 2 mg/mL: 5 units = 100 mcg, 15 units = 300 mcg
Lyophilized: -20°C; Reconstituted: 2-8°C for up to 4 weeks
| Week | Daily Dose | Units (per injection) |
|---|---|---|
| Weeks 1-2 | 100 mcg 2x daily | 5 units AM + 5 units PM |
| Weeks 3-4 | 100 mcg 3x daily | 5 units 3x daily |
| Weeks 5-12 | 200-300 mcg 2-3x daily | 10-15 units per dose |
- 1Draw 2.5 mL bacteriostatic water with a sterile syringe
- 2Inject slowly down the vial wall to prevent foaming
- 3Gently swirl until fully dissolved - do not shake
- 4Label with date and concentration, refrigerate immediately
CJC-1295 NO DAC is a tetrasubstituted GHRH(1-29) analog that stimulates pulsatile GH release from the pituitary. Unlike the DAC version, it has a half-life of approximately 30 minutes, allowing for more physiological GH pulses. Often combined with GHRPs for enhanced effect.
- Stimulates natural GH release pattern
- Shorter half-life mimics natural physiology
- Synergistic with GHRP peptides
- May support recovery and body composition
- Teichman SL, et al. Prolonged stimulation of growth hormone. J Clin Endocrinol Metab. 2006
- Alba M, et al. Once-daily administration of CJC-1295. J Clin Endocrinol Metab. 2006
- GHRH analog research and GH secretagogue studies
Lyophilized
Store at -20°C, protected from light
Reconstituted
Refrigerate at 2-8°C, use within 4 weeks
Best combined with GHRP for synergistic effects
- •Research compound - not FDA approved
- •Best used with GHRP (Ipamorelin, GHRP-6)
- •Inject on empty stomach for best results
- •Multiple daily doses required due to short half-life
Disclaimer: This content is intended for research and educational purposes only. Not intended to diagnose, treat, cure, or prevent any disease. All compounds are for research use only. Dosing information is derived from published scientific literature and clinical studies.